Found: 4
Select item for more details and to access through your institution.
Combining the G-protein-coupled receptor 40 agonist fasiglifam with sitagliptin improves glycaemic control in patients with type 2 diabetes with or without metformin: A randomized, 12-week trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 8, p. 1127, doi. 10.1111/dom.12921
- By:
- Publication type:
- Article
965-P: Real-World Evidence of the Effect on Glycemic Control with Relatively Simultaneous vs. Sequential Initiation of Basal Insulin and GLP-1 Receptor Agonists.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-965-P
- By:
- Publication type:
- Article
345-OR: A Retrospective U.S. Real-World Evidence Study on Glycemic Goal Achievement within 2 Years Post-Basal Insulin Initiation.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-345-OR
- By:
- Publication type:
- Article
1116-P: Glycemic Outcomes and Persistence with Basal Insulin and Glucagon-Like Peptide-1 Receptor Agonists among Patients with T2D: Simultaneous vs. Sequential Initiation.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1116-P
- By:
- Publication type:
- Article